The role of Helicobacter pylori in paediatrics

Y Vandenplas1

  • 1Academic Children's Hospital, Free University of Brussels, Brussels, Belgium. pedvsy@az.vub.ac.be

Insights

Helicobacter pylori (H. pylori) infection in children remains controversial due to limited scientific data. Further research is needed to clarify clinical relevance, diagnosis, and treatment guidelines for H. pylori in pediatric populations.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Infectious Diseases

Background:

  • Helicobacter pylori (H. pylori) is a common bacterium colonizing the human stomach, particularly in childhood.
  • Despite extensive research, significant controversies persist regarding H. pylori's clinical relevance, diagnostic methods, treatment indications, and symptom profiles, especially in pediatric cases.

Purpose of the Study:

  • To review recent literature (past 2 years) on Helicobacter pylori in children.
  • To highlight existing controversies and identify gaps in scientific data concerning pediatric H. pylori infections.

Main Methods:

  • Literature review of studies published within the last two years.
  • Analysis of existing research focusing on pediatric H. pylori infections.

Main Results:

  • The review identifies a significant lack of high-quality, double-blind, placebo-controlled studies in children.
  • This paucity of robust data contributes to ongoing disagreements on critical aspects of H. pylori management in pediatric patients.

Conclusions:

  • Substantial scientific evidence gaps hinder definitive conclusions regarding H. pylori in children.
  • Further rigorous research, particularly placebo-controlled trials, is essential to resolve current controversies and establish clear guidelines for pediatric H. pylori management.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...